KRAS is commonly considered the worst of the three RAS GTPases for cancer promotion; our pan-cancer analysis rather suggests that the issue of which oncogenic RAS GTPase is most cancer-promoting may be dependent upon the type of cell in which cancer develops. The gene discussed is KRAS; the disease is cancer.